Publications by authors named "Anna Mariana"

Claim this Profile
F
FDA-approved disulfiram as a novel treatment for aggressive leukemia.
Mawar Karsa, Lin Xiao, Emma Ronca, Angelika Bongers, Dayna Spurling, Anna Mariana

J Mol Med (Berl)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasion-Block and S-MARVEL: A high-content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasis.
Dajiang Guo, Russell Jurek, Kimberley A Beaumont, Danae S Sharp, Sioh-Yang Tan, Anna Mariana

Proc Natl Acad Sci U S A· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia.
Mawar Karsa, Emma Ronca, Angelika Bongers, Anna Mariana, Ernest Moles

Front Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia.
Julia W Bӧhm, Keith C S Sia, Connor Jones, Kathryn Evans, Anna Mariana

Leukemia· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.
Mawar Karsa, Angelika Kosciolek, Angelika Bongers, Anna Mariana, Tim Failes

Br J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,8-Naphthalimide derivatives: new leads against dynamin I GTPase activity.
Mohammed K Abdel-Hamid, Kylie A Macgregor, Luke R Odell, Ngoc Chau, Anna Mariana

Org Biomol Chem· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis.
Adam McCluskey, James A Daniel, Gordana Hadzic, Ngoc Chau, Emma L Clayton, Anna Mariana

Traffic· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors.
Andrew B McGeachie, Luke R Odell, Annie Quan, James A Daniel, Ngoc Chau, Anna Mariana

ACS Chem Biol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of second-generation indole-based dynamin GTPase inhibitors.
Christopher P Gordon, Barbara Venn-Brown, Mark J Robertson, Kelly A Young, Ngoc Chau, Anna Mariana

J Med Chem· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity.
Mark J Robertson, Gordana Hadzic, Joseph Ambrus, D Yuri Pomè, Emily Hyde, Anna Mariana

ACS Med Chem Lett· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism.
Callista B Harper, Sally Martin, Tam H Nguyen, Shari J Daniels, Nickolas A Lavidis, Anna Mariana

J Biol Chem· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells.
Megan Chircop, Swetha Perera, Anna Mariana, Hui Lau, Maggie P C Ma

Mol Cancer Ther· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cells.
Sanket Joshi, Swetha Perera, Jayne Gilbert, Charlotte M Smith, Anna Mariana

Mol Cancer Ther· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pthaladyns: GTP competitive inhibitors of dynamin I and II GTPase derived from virtual screening.
Luke R Odell, Dian Howan, Christopher P Gordon, Mark J Robertson, Ngoc Chau, Anna Mariana

J Med Chem· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis.
Timothy A Hill, Anna Mariana, Christopher P Gordon, Luke R Odell, Mark J Robertson

J Med Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azido and diazarinyl analogues of bis-tyrphostin as asymmetrical inhibitors of dynamin GTPase.
Luke R Odell, Ngoc Chau, Anna Mariana, Mark E Graham, Phillip J Robinson

ChemMedChem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles.
Timothy A Hill, Christopher P Gordon, Andrew B McGeachie, Barbara Venn-Brown, Luke R Odell, Anna Mariana

J Med Chem· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microprobe XRF mapping and XAS investigations of the intracellular metabolism of arsenic for understanding arsenic-induced toxicity.
Kristie L Munro, Anna Mariana, Andrejs I Klavins, Amalanie J Foster, Barry Lai

Chem Res Toxicol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis